New Delhi is witnessing a shift in health awareness as experts debunk the myth that HPV vaccines are solely for women. Dr. Meera Pathak, a leading voice in public health, emphasizes that the Human Papillomavirus affects both genders equally, posing severe risks including cancers that often go unnoticed until it’s too late.
HPV, with over 200 strains, spreads primarily through sexual contact. Many infections remain symptomless, allowing unwitting transmission between partners. This silent spread underscores the urgency for widespread vaccination.
High-risk strains like 16 and 18 are notorious for causing cervical cancer in women, but in men, they trigger penile, anal, oral, and oropharyngeal cancers. Genital warts from low-risk strains add physical discomfort and emotional distress, yet they’re frequently dismissed.
Dr. Pathak warns that limiting vaccines to females leaves men vulnerable and perpetuates the virus cycle. Vaccinating boys breaks this chain, protecting individuals and communities. Globally, programs target both genders for maximum impact.
The optimal window for vaccination is ages 9-14, when immunity response is strongest and before sexual activity begins. Two doses suffice in this range, spaced six months apart. For those 15 and older, a three-dose regimen is recommended: initial dose, followed by second at 1-2 months, and third at six months.
India offers options like Cervarix, Gardasil 4, Gardasil 9, and the locally produced Cervavac. Gardasil 9 covers the most strains, while Cervavac provides affordable protection against four key types. Consultation with a doctor ensures the best choice.
Concerns about side effects are unfounded; mild reactions like injection-site soreness or low fever resolve quickly. This safe intervention could slash HPV-related diseases dramatically.
As awareness grows, embracing HPV vaccination for all is a proactive step toward healthier futures, urging parents and adults alike to act now.